Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Grazia Recchia

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Current Cancer Drug Targets|June 8, 2012
Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millenniumFortunato Morabito, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Emerging Drugs|August 28, 2012
Emerging biological insights and novel treatment strategies in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Journal of Immunology Research|January 21, 2016
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewRoberta Fedele, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|March 22, 2016
Sorafenib for the treatment of multiple myelomaMassimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Biological Therapy|March 27, 2012
Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Massimo Martino, Roberta Fedele, Elisabetta Massara, et al.
Journal of Molecular and Cellular Cardiology|December 30, 2008
Endothelin-1 induces connective tissue growth factor expression in cardiomyocytesAnna Grazia Recchia, Elisabetta Filice, Daniela Pellegrino, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Molecular Endocrinology (Baltimore, Md.)|October 22, 2005
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cellsAdele Vivacqua, Daniela Bonofiglio, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Current Cancer Drug Targets|June 8, 2012
Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millenniumFortunato Morabito, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Emerging Drugs|August 28, 2012
Emerging biological insights and novel treatment strategies in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Journal of Immunology Research|January 21, 2016
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewRoberta Fedele, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|March 22, 2016
Sorafenib for the treatment of multiple myelomaMassimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Biological Therapy|March 27, 2012
Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Massimo Martino, Roberta Fedele, Elisabetta Massara, et al.
Journal of Molecular and Cellular Cardiology|December 30, 2008
Endothelin-1 induces connective tissue growth factor expression in cardiomyocytesAnna Grazia Recchia, Elisabetta Filice, Daniela Pellegrino, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Molecular Endocrinology (Baltimore, Md.)|October 22, 2005
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cellsAdele Vivacqua, Daniela Bonofiglio, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Pageof 7